Clinical Trials Logo

Delirium clinical trials

View clinical trials related to Delirium.

Filter by:

NCT ID: NCT05081726 Not yet recruiting - Hip Fractures Clinical Trials

fMRI Feasibility Older Hip Fracture Surgery

Start date: July 4, 2022
Phase:
Study type: Observational

An assessment of the feasibility of structural and functional magnetic resonance imaging (MRI) brain scans in older people who have recovered from and older people who never had delirium after hip fracture surgery

NCT ID: NCT05076162 Completed - Delirium Clinical Trials

Vitamin D Level and Emergence Delirium in Children

Start date: February 1, 2019
Phase:
Study type: Observational [Patient Registry]

In our study, we aimed to evaluate the relationship between vitamin D levels and postoperative delirium in children who had undergone tonsillectomy and/or adenoidectomy.

NCT ID: NCT05069428 Recruiting - Delirium Clinical Trials

Delirium Reduction With Ramelteon

DREAM
Start date: March 26, 2023
Phase: Phase 4
Study type: Interventional

The overall purpose of this study is to identify a medication that might treat and/or prevent delirium in intensive care unit (ICU). Currently, there is no proven medical therapy for prevention or treatment of delirium. Ramelteon is a medication approved for insomnia. We hypothesize that ramelteon may help regulate the day/night cycle and decrease ICU delirium.

NCT ID: NCT05068180 Recruiting - Prostatic Neoplasms Clinical Trials

Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients

Start date: October 5, 2021
Phase: Phase 4
Study type: Interventional

Postoperative delirium(POD)is a common complication that can directly affect important clinical outcomes, and exert an enormous burden on patients, their families, hospitals, and public resources. In order to evaluate whether an intraoperative administration of low-dose neuroleptanalgesia reduces postoperative delirium, droperidol 1.25 mg and fentanyl 0.025 mg or normal saline is used by intravenous injection 30 minutes before the end of the operation, in elderly patients with non-cardiac major surgery under general anesthesia. The efficiency and safety of neuroleptanalgesia on the incidence of POD would be evaluated in elderly patients.

NCT ID: NCT05066503 Recruiting - Subacute Delirium Clinical Trials

Nutritional Therapy for Delirium in Elderly Hospitalized Subjects

Start date: November 16, 2020
Phase: N/A
Study type: Interventional

The investigators have developed a proprietary blend of amino acids that they think will help to prevent or reduce the severity of delirium in older people who are hospitalized for certain infections. In this study, up to 45 people will be enrolled. 15 will be asked to drink this blend twice a day for up to 4 days, and 15 will drink a placebo (sugar water) for the same time period. The other 15 subjects will be non-delirious control subjects who do not consume any study products.

NCT ID: NCT05060614 Recruiting - Delirium Clinical Trials

Analyses of Cerebrospinalfluid in Patients With Delirium

Start date: September 1, 2016
Phase:
Study type: Observational

The current project aims to measure biomarkers in the cerebrospinalfluid (CSF) and serum samples from patients with delirium. We hope to uncover new insights into the pathophysiology of delirium and explore its link to dementia.

NCT ID: NCT05055895 Recruiting - Alzheimer Disease Clinical Trials

Association of Anticholinergic Burden With Onset of Delirium in Older Adults With Alzheimer Dementia:

Start date: January 1, 2005
Phase:
Study type: Observational

Drugs with anticholinergic properties are commonly prescribed to older persons despite growing evidence of their significant adverse effects. However, limited data are available concerning their contribution to time of onset of delirium. This study aimed to determine the potential association of higher anticholinergic burden to early-onset of delirium superimposed dementia in the older adult.

NCT ID: NCT05053724 Completed - Clinical trials for Mechanical Ventilation Complication

Efficacy of the "Start to Move" Protocol on Functionality, Delirium and Acquired Weakness in ICU

STM
Start date: January 1, 2018
Phase: N/A
Study type: Interventional

Background: ICU hospitalization is associated with loss of strength, functionality and delirium. The "Start to Move protocol" demonstrated efficacy in improving and minimizing such effects. Aim: To evaluate the effectiveness of the "Start to move protocol" compared with conventional treatment in ICU subjects on functionality, weakness acquired in the Intensive Care Unit (ICU-AW), incidence of delirium, days of invasive mechanical ventilation (IMV), ICU stay and 28-day mortality. Methods: Randomized controlled clinical trial. Including adults ≥15 years with IMV >48 hours, randomized into Start to move and conventional treatment groups.Functionality, ICU-AW incidence, delirium incidence, IMV days, ICU stay and mortality-28 days were analyzed.

NCT ID: NCT05036538 Recruiting - Clinical trials for Postoperative Delirium

Decreasing Preoperative Stress to Prevent Postoperative Delirium and Postoperative Cognitive Decline in Cardiac Surgical Patients.

DESTRESS-SURG
Start date: July 27, 2023
Phase: N/A
Study type: Interventional

Patients undergoing cardiac surgery often complain of anxiety before a major operation and the resulting stress. This circumstance is a risk factor for mental problems that may occur after the operation (e.g., delirium or memory deficits). This study aims to prevent these discomforts by a preoperative relaxation intervention.

NCT ID: NCT05029050 Recruiting - Delirium Clinical Trials

Dexmedetomidine or Clonidine Infusion for Prevention of Delirium After Open Heart Surgery

ALPHA2PREVENT
Start date: January 17, 2022
Phase: Phase 4
Study type: Interventional

A parallel-group treatment, five-centre, participant and investigator masked, three-arm study to assess the safety and effectiveness of dexmedetomidine or clonidine infusion compared to placebo for the prevention of delirium and cognitive decline in male and female participants aged 70+ scheduled for open heart surgery.